Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIPRETINIB vs RISEDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIPRETINIB vs RISEDRONATE: Safety Overview

Metric RIPRETINIB RISEDRONATE
Total FAERS Reports 4,432 6,768
Deaths Reported 465 202
Death Rate 10.5% 3.0%
Hospitalizations 948 1,825
Average Patient Age 66.8 yrs 68.0 yrs
% Female Patients 45.3% 92.3%
FDA Approval Date May 15, 2020 Apr 14, 2000
Manufacturer Deciphera Pharmaceuticals, LLC Aurobindo Pharma Limited
Route ORAL ORAL
Marketing Status Prescription Discontinued